HLA-C Genotypes and Kidney Transplant Outcomes
Author Information
Author(s): Hanvesakul Raj, Kubal Chandrashekhar, Moore Jason, Neil Desley, Cook Mark, Ball Simon, Briggs David, Moss Paul, Cockwell Paul
Primary Institution: Renal Institute of Birmingham, University Hospital Birmingham, Birmingham, United Kingdom
Hypothesis
The interaction between donor-derived NK cells and recipient dendritic cells is influenced by the recipient's HLA-C genotype, affecting graft survival.
Conclusion
Recipients with the HLA-C2 allele have significantly better long-term graft survival compared to those without it.
Supporting Evidence
- Transplant recipients with HLA-C2 had 66% graft survival at 10 years compared to 44% for HLA-C1.
- Donor-derived NK cells were confirmed present in pre-transplant kidneys.
- IL-15 activation of NK cells was shown to influence dendritic cell maturation.
Takeaway
If you have a certain gene called HLA-C2, your kidney transplant is more likely to work well for a long time.
Methodology
The study involved genotyping kidney transplant recipients and analyzing their long-term graft survival based on HLA-C genotypes.
Potential Biases
Potential biases may arise from the retrospective nature of the study and the specific population studied.
Limitations
The study did not account for all potential confounding factors affecting graft survival.
Participant Demographics
The study included 760 kidney transplant recipients, with a mix of first-time and re-transplant cases.
Statistical Information
P-Value
0.002
Confidence Interval
95% CI: 1.16–1.97
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website